Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.